Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-02-01 Sale | 2021-02-02 9:47 pm | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 30,000 | $126.73 | $3,801,918 | 581,796 (Direct) | View |
| 2019-09-10 Purchase | 2019-09-11 4:16 pm | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 2,222 | $45 | $99,990 | 2,222 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-26 Disposition | 2024-02-27 4:51 pm | N/A 2031-03-18 | RayzeBio Inc. | RYZB | Larson Yi Director | 114,579 | $0 | 0 (Direct) | View |
Ownership | 2023-09-14 7:27 pm | N/A 2031-03-18 | RayzeBio Inc. | RYZB | Larson Yi Director | 0 | $0 | 114,579 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:00 pm | N/A 2033-06-15 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 4:17 pm | N/A N/A | LianBio | LIAN | Larson Yi Chief Financial Officer | 325,901 | $0 | 325,901 (Direct) | View |
| 2023-01-20 Option Award | 2023-01-24 4:12 pm | N/A 2033-01-20 | LianBio | LIAN | Larson Yi Chief Financial Officer | 464,099 | $0 | 464,099 (Direct) | View |
| 2022-06-17 Option Award(A) | 2022-06-27 5:16 pm | N/A 2032-06-16 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2022-06-16 Option Award | 2022-06-17 7:32 pm | N/A 2032-06-15 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2021-12-01 Option Award | 2021-12-03 4:05 pm | N/A 2031-12-01 | LianBio | LIAN | Larson Yi Chief Financial Officer | 5,996 | $0 | 1,202,841 (Direct) | View |
| 2021-10-31 Option Award | 2021-11-01 7:20 pm | N/A 2031-10-31 | LianBio | LIAN | Larson Yi Chief Financial Officer | 229,538 | $0 | 1,196,845 (Direct) | View |
Ownership | 2021-10-29 6:16 pm | N/A 2021-05-03 | LianBio | LIAN | Larson Yi Chief Financial Officer | 0 | $0 | 969,307 (Direct) | View |
| 2021-06-09 Option Award | 2021-06-10 6:36 pm | N/A 2031-06-08 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 21,520 | $0 | 21,520 (Direct) | View |
| 2021-04-05 Option Award | 2021-04-06 7:49 pm | N/A 2031-04-04 | Olema Pharmaceuticals Inc. | OLMA | Larson Yi Director | 25,293 | $0 | 25,293 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:58 pm | N/A 2031-02-07 | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 25,392 | $0 | 28,096 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A N/A | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 30,000 | $54.03 | 581,796 (Direct) | View |
| 2021-02-01 Exercise | 2021-02-02 9:47 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 30,000 | $0 | 581,796 (Direct) | View |
| 2020-01-06 Option Award | 2020-01-08 4:18 pm | N/A 2030-01-05 | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 33,000 | $0 | 33,000 (Direct) | View |
| 2019-08-26 Option Award | 2019-08-27 4:27 pm | N/A 2029-08-25 | Turning Point Therapeutics Inc. | TPTX | Larson Yi EVP & Chief Financial Officer | 312,397 | $0 | 312,397 (Direct) | View |